M&A / Deals Eli Lilly to Acquire Kelonia Therapeutics Big Molecule WatchOn April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.Read full story pharminent May 4, 2026 (Last updated: May 4, 2026) Big Molecule Watch On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc. Read full story Post navigation Previous: Gene therapy’s evidence problem–lessons from recent FDA decisionsNext: 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
